Generic placeholder image

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Research Article

In vitro Synthesis, Structure Elucidation, and Antioxidant Properties of Platinum(IV)-hydrazide Complexes: Molecular Modeling of Free- Hydrazides Suggested as Potent Lipoxygenase Inhibitor

Author(s): Rooma Badar, Uzma Ashiq *, Rifat Ara Jamal, Parveen Akhter, Mohammad Mahroof-Tahir, Sana Gul and Syed Tahir Ali

Volume 18, Issue 1, 2022

Published on: 16 February, 2021

Page: [97 - 114] Pages: 18

DOI: 10.2174/1573406417666210216160941

Price: $65

Abstract

Background: A combination of biologically active ligand and metal in one molecule may increase the activity and reduce the toxicity.

Objectives: In this study, the synthesis and characterization of platinum(IV) complexes with bioactive hydrazide ligands are discussed.

Method: Elemental analysis, conductivity measurements, and spectroscopic studies were used to elucidate the structure of complexes.

Results: Our study suggests that hydrazide ligands coordinate with Pt(IV) in a bidentate fashion. The platinum(IV) complexes have octahedral geometry with a metal to ligand ratio of 1:2. Hydrazide ligands were coordinated with central metal platinum(IV) by oxygen of carbonyl group and nitrogen of primary amine. Synthesized complexes exhibited variable DPPH radical scavenging and lipoxygenase inhibition activity. Furthermore, it is also found that Pt(IV)-hydrazide complexes are more potent superoxide and nitric oxide radical scavengers than their uncoordinated hydrazide ligands, while in the case of lipoxygenase enzyme inhibition, some of the free hydrazide ligands are more active than their respective Pt(IV) complexes. In silico docking technique explores molecular interactions of synthesized ligands in the active site of the lipoxygenase enzyme. Predicted docking energies are in good agreement with experimental data suggesting that in silico studies might be useful for the discovery of therapeutic candidates.

Conclusion: Structure-function relationship demonstrates that the radical scavenging and enzyme inhibition activities of the Pt(IV) compounds are affected by the nature of the ligand, position of substituent, electronic and steric effects. However, electronic factors seem to play a more important role than other factors.

Keywords: DPPH radical, superoxide, nitric oxide, lipoxygenase, platinum(IV), hydrazide, in silico docking.

Graphical Abstract
[1]
Lippard, S.J. Bioinorganic Chemistry; University Science Books Mill Valley: California, 1994, p. 505.
[2]
Chandra, S.; Pundir, M. Spectroscopic characterization of chromium(III), manganese(II) and nickel(II) complexes with a nitrogen donor tetradentate, 12-membered azamacrocyclic ligand. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2008, 69(1), 1-7.
[http://dx.doi.org/10.1016/j.saa.2007.02.019] [PMID: 17482510]
[3]
Chandra, S.; Gupta, L.K.; Agrawal, S. Synthesis spectroscopic and biological approach in the characterization of novel [N4] macrocyclic ligand and its transition metal complexes. Transit. Met. Chem., 2007, 232, 558-563.
[http://dx.doi.org/10.1007/s11243-007-0201-y]
[4]
Chandra, S.; Gupta, R.; Gupta, N.; Bawa, S.S. Transit. Met. Chem., 2006, 31, 147-151.
[http://dx.doi.org/10.1007/s11243-005-6194-5]
[5]
Rau, T.; van Eldik, R. Metal Ions in Biological Systems; Marcel Dekker, New York 1996, 31, pp. 339-378.
[6]
Ul Ain, Q.; Ashiq, U.; Jamal, R.A.; Mahrooof-Tahir, M. Synthesis, spectroscopic and radical scavenging studies of palladium(II)-hydrazide complexes. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2013, 115, 683-689.
[http://dx.doi.org/10.1016/j.saa.2013.05.064] [PMID: 23880410]
[7]
Vetter, C.; Wagner, C.; Schmidt, J.; Steinborn, D. Synthesis and characterization of platinum (IV) complexes with N, S and S, S heterocyclic ligands. Inorg. Chim. Acta, 2006, 359, 4326-4334.
[http://dx.doi.org/10.1016/j.ica.2006.06.007]
[8]
Keppler, B.K.; Lipponer, K.G.; Stenzel, B.; Kratz, F. New tumor-inhibiting ruthenium complexes.metal complexes in cancer chemotherapy. VCH Verlagsgesellschaft; VCH Publishers: Weinheim, NY, 1993, pp. 187-220.
[9]
Junicke, H.; Kluge, R.; Steinborn, D. Synthesis and characterization of novel platinum(IV) complexes with non-functionalized acetylated carbohydrates. J. Inorg. Biochem., 2000, 81(1-2), 43-48.
[http://dx.doi.org/10.1016/S0162-0134(00)00088-X] [PMID: 11001430]
[10]
Struck, R.F.; Kirk, M.C.; Rice, L.S.; Suling, W.J. Isolation, synthesis, and antitumor evaluation of spirohydantoin aziridine, a mutagenic metabolite of spirohydantoin mustard. J. Med. Chem., 1986, 29(7), 1319-1321.
[http://dx.doi.org/10.1021/jm00157a039] [PMID: 3543361]
[11]
Bakalova, A.; Buyukliev, R.; Momekov, G.; Ivanov, D.; Todorov, D.; Konstantinov, S.; Karaivanova, M. Synthesis, physicochemical and in vitro pharmacological investigation of new platinum (II) complexes with some cycloalkanespiro-5′-hydantoins. Eur. J. Med. Chem., 2005, 40(6), 590-596.
[http://dx.doi.org/10.1016/j.ejmech.2005.01.009] [PMID: 15922842]
[12]
Varbanov, H.; Valiahdi, S.M.; Legin, A.A.; Jakupec, M.A.; Roller, A.; Galanski, M.; Keppler, B.K. Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin. Eur. J. Med. Chem., 2011, 46(11), 5456-5464.
[http://dx.doi.org/10.1016/j.ejmech.2011.09.006] [PMID: 21940073]
[13]
Hall, M.D.; Mellor, H.R.; Callaghan, R.; Hambley, T.W. Basis for design and development of platinum(IV) anticancer complexes. J. Med. Chem., 2007, 50(15), 3403-3411.
[http://dx.doi.org/10.1021/jm070280u] [PMID: 17602547]
[14]
Galanski, M. Recent developments in the field of anticancer platinum complexes. Recent Patents Anticancer Drug Discov., 2006, 1(2), 285-295.
[http://dx.doi.org/10.2174/157489206777442287] [PMID: 18221042]
[15]
Ellis, L.T.; Er, H.M.; Hambley, T.W. The influence of the axial ligands of a series of platinum (IV) anti-cancer complexes on their reduction to platinum (II) and reaction with DNA. Aust. J. Chem., 1995, 48, 793-806.
[http://dx.doi.org/10.1071/CH9950793]
[16]
Rollas, S.; Gulerman, N.; Erdeniz, H. Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Farmaco, 2002, 57(2), 171-174.
[http://dx.doi.org/10.1016/S0014-827X(01)01192-2] [PMID: 11902660]
[17]
Deepa, K.P.; Aravindakshan, K.K. Synthesis, characterization, and antifungal studies of transition metal complexes of omega-bromoacetoacetanilide isonicotinylhydrazone. Appl. Biochem. Biotechnol., 2004, 118(1-3), 283-292.
[http://dx.doi.org/10.1385/ABAB:118:1-3:283] [PMID: 15304756]
[18]
Judge, V.; Narasimhan, B.; Ahuja, M.; Sriram, D.; Yogeeswari, P.; De Clercq, E.; Pannecouque, C.; Balzarini, J. Isonicotinic acid hydrazide derivatives: synthesis, antimicrobial activity, and QSAR studies. Med. Chem. Res., 2012, 21, 1451-1470.
[http://dx.doi.org/10.1007/s00044-011-9662-9]
[19]
Buss, J. L.; Hermes-Lima, M.; Ponka, P. Pyridoxalisonicotinoylhydrazone and its analogues.Iron chelation therapy; Springer US 2002, pp. 205-229.
[20]
Fridovich, I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem., 1995, 64, 97-112.
[http://dx.doi.org/10.1146/annurev.bi.64.070195.000525] [PMID: 7574505]
[21]
Ivanova, E.; Ivanov, B. Mechanisms of the extracellular antioxidant defend. Exp Pathol Parasitol, 2000, 4, 49-59.
[22]
González-Álvarez, M.; Alzuet, G.; Borrás, J.; del Castillo Agudo, L. GarcA-a-Granda, S.; Montejo-Bernardo, J.M. Comparison of protective effects against reactive oxygen species of mononuclear and dinuclear Cu(II) complexes with N-substituted benzothiazolesulfonamides. Inorg. Chem., 2005, 44(25), 9424-9433.
[http://dx.doi.org/10.1021/ic050110c] [PMID: 16323929]
[23]
Kachadourian, R.; Flaherty, M.M.; Crumbliss, A.L.; Patel, M.; Day, B.J. Synthesis and in vitro antioxidant properties of manganese(III) Iβ-octabromo-meso-tetrakis(4-carboxyphenyl)porphyrin. J. Inorg. Biochem., 2003, 95(4), 240-248.
[http://dx.doi.org/10.1016/S0162-0134(03)00135-1] [PMID: 12818794]
[24]
Liczmanski, A.E.; Hartmann, H.J.; Weser, U. Bulletin of the polish academy of sciences. Biol. Sci, 1994, 42, 291-297.
[25]
Nagano, T.; Hirano, T.; Hirobe, M. Superoxide dismutase mimics based on iron in vivo. J. Biol. Chem., 1989, 264(16), 9243-9249.
[http://dx.doi.org/10.1016/S0021-9258(18)60521-6] [PMID: 2542303]
[26]
Kimura, E.; Yatsunami, A.; Watanabe, A.; Machida, R.; Koike, T.; Fujioka, H.; Kuramoto, Y.; Sumomogi, M.; Kunimitsu, K.; Yamashita, A. Further studies on superoxide dismutase activities of macrocyclic polyamine complexes of copper(II). Biochim. Biophys. Acta, 1983, 745(1), 37-43.
[http://dx.doi.org/10.1016/0167-4838(83)90167-X] [PMID: 6687811]
[27]
Balasundram, N.; Ai, T.Y.; Sambanthamurthi, R.; Sundram, K.; Samman, S. Antioxidant properties of palm fruit extracts. Asia Pac. J. Clin. Nutr., 2005, 14(4), 319-324.
[PMID: 16326638]
[28]
Patel Rajesh, M.; Patel Natvar, J. In vitro antioxidant activity of coumarin compounds by DPPH, super oxide and nitric oxide free radical scavenging methods. J. Adv. Pharm. Educ. Res., 2011, 1, 52-68.
[29]
Bencini, A.; Failli, P.; Valtancoli, B.; Bani, D. Low molecular weight compounds with transition metals as free radical scavengers and novel therapeutic agents. Cardiovasc. Hematol. Agents Med. Chem., 2010, 8(3), 128-146.
[http://dx.doi.org/10.2174/187152510791698389] [PMID: 20438441]
[30]
Srivastava, P.; Vyas, V.K.; Variya, B.; Patel, P.; Qureshi, G.; Ghate, M. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives. Bioorg. Chem., 2016, 67, 130-138.
[http://dx.doi.org/10.1016/j.bioorg.2016.06.004] [PMID: 27376460]
[31]
Maqsood, Z.T.; Khan, K.M.; Ashiq, U.; Jamal, R.A.; Chohan, Z.H.; Mahroof-Tahir, M.; Supuran, C.T. Oxovanadium(IV) complexes of hydrazides: potential antifungal agents. J. Enzyme Inhib. Med. Chem., 2006, 21(1), 37-42.
[http://dx.doi.org/10.1080/14756360500277459] [PMID: 16570503]
[32]
Ara, R.; Ashiq, U.; Mahroof-Tahir, M.; Maqsood, Z.T.; Khan, K.M.; Lodhi, M.A.; Choudhary, M.I. Chemistry, urease inhibition, and phytotoxic studies of binuclear vanadium(IV) complexes. Chem. Biodivers., 2007, 4(1), 58-71.
[http://dx.doi.org/10.1002/cbdv.200790007] [PMID: 17256735]
[33]
Khan, K.M.; Rasheed, M. Zia-Ullah; Hayat, S.; Kaukab, F.; Choudhary, M.I.; Atta-ur-Rahman; Perveen, S. Synthesis and in vitro leishmanicidal activity of some hydrazides and their analogues. Bioorg. Med. Chem., 2003, 11(7), 1381-1387.
[http://dx.doi.org/10.1016/S0968-0896(02)00611-9] [PMID: 12628664]
[34]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65(1-2), 55-63.
[http://dx.doi.org/10.1016/0022-1759(83)90303-4] [PMID: 6606682]
[35]
Sladowski, D.; Steer, S.J.; Clothier, R.H.; Balls, M. An improved MTT assay. J. Immunol. Methods, 1993, 157(1-2), 203-207.
[http://dx.doi.org/10.1016/0022-1759(93)90088-O] [PMID: 8423364]
[36]
Lee, S.K.; Mbwambo, Z.H.; Chung, H.; Luyengi, L.; Gamez, E.J.; Mehta, R.G.; Kinghorn, A.D.; Pezzuto, J.M. Evaluation of the antioxidant potential of natural products. Comb. Chem. High Throughput Screen., 1998, 1(1), 35-46.
[PMID: 10499128]
[37]
de Gaulejac, N.S.C.; Glories, Y.; Vivas, N. Free radical scavenging effect of anthocyanins red wines. Food Res. Int., 1999, 32, 327-333.
[http://dx.doi.org/10.1016/S0963-9969(99)00093-9]
[38]
Badami, S.; Gupta, M.K.; Suresh, B. Antioxidant activity of the ethanolic extract of Striga orobanchioides. J. Ethnopharmacol., 2003, 85(2-3), 227-230.
[http://dx.doi.org/10.1016/S0378-8741(03)00021-7] [PMID: 12639745]
[39]
Tappel, A.L. The mechanism of the oxidation of unsaturated fatty acids catalyzed by hematin compounds. Arch. Biochem. Biophys., 1953, 44(2), 378-395.
[http://dx.doi.org/10.1016/0003-9861(53)90056-3] [PMID: 13058395]
[41]
Reddy, K.K.; Vidya Rajan, V.K.; Gupta, A.; Aparoy, P.; Reddanna, P. Exploration of binding site pattern in arachidonic acid metabolizing enzymes. Cyclooxygenases and Lipoxygenases. BMC Res. Notes, 2015, 8, 152.
[http://dx.doi.org/10.1186/s13104-015-1101-4] [PMID: 25886468]
[42]
Gilbert, N.C.; Bartlett, S.G.; Waight, M.T.; Neau, D.B.; Boeglin, W.E.; Brash, A.R.; Newcomer, M.E. The structure of human 5-lipoxygenase. Science, 2011, 331(6014), 217-219.
[http://dx.doi.org/10.1126/science.1197203] [PMID: 21233389]
[44]
Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, V. and Informatics at the University of California, San Francisco.
[45]
Dennington, R.; Keith, T.A.; Millam, J.M. Semichem Inc., 2016.
[46]
Gaussian 16, R.C.; Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.
[47]
Poirier, R.; Kari, R.; Csizmadia, I.G. Handbook of Gaussian basis sets; , 1985.
[48]
Grosdidier, A.; Zoete, V.; Michielin, O. Fast docking using the CHARMM force field with EADock DSS. J. Comput. Chem., 2011, 32(10), 2149-2159.
[http://dx.doi.org/10.1002/jcc.21797] [PMID: 21541955]
[49]
Geary, W.J. The use of conductivity measurements in organic solvents for the characterization of coordination compounds. Coord. Chem. Rev., 1971, 7, 81-122.
[http://dx.doi.org/10.1016/S0010-8545(00)80009-0]
[50]
Vogel, A.I. A Text-Book of Quantitative Inorganic Analysis-Theory and Practice; Longmans, Green And Co.: London; New York; Toronto , 2013.
[51]
Georgieva, M.; Andonovski, B. Study of the Reaction of Platinum (IV) with Dimethylglyoxime by UV Spectrophotometry. Coll.Czechoslo. Chem. Comm., 2003, 68, 1065-1075.
[http://dx.doi.org/10.1135/cccc20031065]
[52]
Mink, L.M.; Neitzel, M.L.; Bellomy, L.M.; Falvo, R.E.; Boggess, R.K.; Trainum, B.T.; Yeaman, P. Platinum (II) and platinum (IV) porphyrin complexes: synthesis, characterization, and electrochemistry. Polyhedron, 1997, 16, 2809-2817.
[http://dx.doi.org/10.1016/S0277-5387(97)00026-0]
[53]
Dodoff, N.; Grancharov, K.; Spassovska, N. Platinum(II) complexes of 4-methoxy- and 4-chlorobenzoic acid hydrazides. Synthesis, characterization, and cytotoxic effect. J. Inorg. Biochem., 1995, 60(4), 257-266.
[http://dx.doi.org/10.1016/0162-0134(95)00025-9] [PMID: 8530921]
[54]
Sultan, S.; Ashiq, U.; Jamal, R.A.; Mahroof-Tahir, M.; Shaikh, Z.; Shamshad, B.; Lateef, M.; Iqbal, L. Vanadium(V) complexes with hydrazides and their spectroscopic and biological properties. Biometals, 2017, 30(6), 873-891.
[http://dx.doi.org/10.1007/s10534-017-0054-6] [PMID: 28994011]
[55]
Mahmoud, E.A.; Sankaranarayanan, J.; Morachis, J.M.; Kim, G.; Almutairi, A. Inflammation responsive logic gate nanoparticles for the delivery of proteins. Bioconjug. Chem., 2011, 22(7), 1416-1421.
[http://dx.doi.org/10.1021/bc200141h] [PMID: 21688843]
[56]
Waters, M.D.; Vaughan, T.O.; Abernethy, D.J.; Garland, H.R.; Cox, C.C.; Coffin, D.L. Toxicity of platinum (IV) salts for cells of pulmonary origin. Environ. Health Perspect., 1975, 12, 45-56.
[http://dx.doi.org/10.1289/ehp.751245] [PMID: 1241674]
[57]
Manjunatha, K.; Poojary, B.; Lobo, P.L.; Fernandes, J.; Kumari, N.S. Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives. Eur. J. Med. Chem., 2010, 45(11), 5225-5233.
[http://dx.doi.org/10.1016/j.ejmech.2010.08.039] [PMID: 20828888]
[58]
Narang, R.; Sharma, S.; Narasimhan, B. Evaluation of anti-inflammatory activity of acid hydrazide derivatives. Hygeia, 2012, 4, 21-26.
[59]
Batinić-Haberle, I.; Rebouças, J.S.; Spasojević, I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid. Redox Signal., 2010, 13(6), 877-918.
[http://dx.doi.org/10.1089/ars.2009.2876] [PMID: 20095865]
[60]
Batinić-Haberle, I.; Spasojević, I.; Hambright, P.; Benov, L.; Crumbliss, A.L.; Fridovich, I. Relationship among redox potentials, proton dissociation constants of pyrrolicnitrogens, and in vivo and in vitro superoxide dismutating activities of manganese (III)and iron (III) water-soluble porphyrins. Inorg. Chem., 1999, 38, 4011-4022.
[http://dx.doi.org/10.1021/ic990118k]
[61]
Soule, B.P.; Hyodo, F.; Matsumoto, K.; Simone, N.L.; Cook, J.A.; Krishna, M.C.; Mitchell, J.B. The chemistry and biology of nitroxide compounds. Free Radic. Biol. Med., 2007, 42(11), 1632-1650.
[http://dx.doi.org/10.1016/j.freeradbiomed.2007.02.030] [PMID: 17462532]
[62]
Ashiq, U.; Jamal, R.A.; Mahroof-Tahir, M.; Maqsood, Z.T.; Khan, K.M.; Omer, I.; Choudhary, M.I. Enzyme inhibition, radical scavenging, and spectroscopic studies of vanadium(IV)-hydrazide complexes. J. Enzyme Inhib. Med. Chem., 2009, 24(6), 1336-1343.
[http://dx.doi.org/10.3109/14756360902888168] [PMID: 19912066]
[63]
Liang, T.; Yue, W.; Li, Q. Comparison of the phenolic content and antioxidant activities of Apocynum venetum L. (Luo-Bu-Ma) and two of its alternative species. Int. J. Mol. Sci., 2010, 11(11), 4452-4464.
[http://dx.doi.org/10.3390/ijms11114452] [PMID: 21151449]
[64]
Shamshad, B.; Jamal, R.A.; Ashiq, U.; Mahrooof-Tahir, M.; Shaikh, Z.; Sultan, S.; Khan, K.M. Studies on chemistry, spectroscopy and antioxidant activities of chromium(III)-hydrazide complexes. Med. Chem., 2015, 11(8), 798-806.
[http://dx.doi.org/10.2174/1573406411666150401103442] [PMID: 25827721]
[65]
Shaikh, Z.; Ashiq, U.; Jamal, R.A.; Mahroof-Tahir, M.; Shamshad, B.; Sultan, S. Chemistry and antioxidant properties of titanium (IV) complexes. Transit. Met. Chem., 2015, 40, 665-671.
[http://dx.doi.org/10.1007/s11243-015-9960-z]
[66]
Solomon, E.I.; Zhou, J.; Neese, F.; Pavel, E.G. New insights from spectroscopy into the structure/function relationships of lipoxygenases. Chem. Biol., 1997, 4(11), 795-808.
[http://dx.doi.org/10.1016/S1074-5521(97)90113-7] [PMID: 9384534]
[67]
Luc, H. Boudreau; GrA(c)goire Lassalle-Claux; Marc Cormier; SA(c)bastien Blanchard; Marco S. Doucet; Marc E. Surette; Mohamed Touaibia. New hydroxycinnamic acid esters as novel 5-lipoxygenase inhibitors that affect leukotriene biosynthesis. Mediators Inflamm., 2017, 20176904634
[http://dx.doi.org/10.1155/2017/6904634]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy